NCT00373542

12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome

A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients With Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 39 (actual)
• Sponsor: GlaxoSmithKline · Industry
• Sex: All
• Age: 18 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the efficacy and safety of ropinirole CR-RLS in the treatment of patients with Restless Legs Syndrome and associated sleep disturbance and period limb movements during sleep.

Conditions

• Restless Legs Syndrome (RLS)
• Restless Legs Syndrome

Interventions

Type	Name	Description
DRUG	ropinirole CR-RLS

Timeline

• Start date: 2006-10-01
• Primary completion: 2007-06-01
• Completion: 2007-06-01
• First posted: 2006-09-08
• Last updated: 2016-10-28

Locations

45 sites across 1 country: United States